Clopidogrel is an adenosine diphosphate receptor antagonist used for the prevention of vascular events in patients with atherothrombotic diseases manifested by recent myocardial infarction, ischemic stroke or peripheral arterial disease. Diarrhoea, rash and pruritus are rather common side effects of clopidogrel. Other side effects include epistaxis, nausea, abdominal pain, vomiting, gastritis, gastric and duodenal ulcer. Thrombocytopenia is the most common laboratory abnormality. Leucopenia and neutropenia are rare. We report three cases of purpuric herpes zoster in patients in therapy with clopidogrel. To our knowledge, only one case of haemorrhagic herpes zoster has been published in a patient in therapy with this drug.

Purpuric herpes zoster in patients in therapy with clopidogrel / S. Veraldi, F. Vaira, G. Nazzaro. - In: JOURNAL OF CLINICAL VIROLOGY. - ISSN 1386-6532. - 69(2015 Aug), pp. 122-124.

Purpuric herpes zoster in patients in therapy with clopidogrel

S. Veraldi
;
F. Vaira;G. Nazzaro
Ultimo
2015

Abstract

Clopidogrel is an adenosine diphosphate receptor antagonist used for the prevention of vascular events in patients with atherothrombotic diseases manifested by recent myocardial infarction, ischemic stroke or peripheral arterial disease. Diarrhoea, rash and pruritus are rather common side effects of clopidogrel. Other side effects include epistaxis, nausea, abdominal pain, vomiting, gastritis, gastric and duodenal ulcer. Thrombocytopenia is the most common laboratory abnormality. Leucopenia and neutropenia are rare. We report three cases of purpuric herpes zoster in patients in therapy with clopidogrel. To our knowledge, only one case of haemorrhagic herpes zoster has been published in a patient in therapy with this drug.
Clopidogrel; Haemorrhagic herpes zoster; Herpes zoster; HIV; Purpuric herpes zoster
Settore MED/35 - Malattie Cutanee e Veneree
Settore MED/17 - Malattie Infettive
ago-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1386653215001730-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 895.43 kB
Formato Adobe PDF
895.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/312226
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 2
social impact